# Approaches to Reduce Toxicity in Pediatric Brain Tumors

**Authors:** Hallie Coltin, Christina Coleman, Chantel Cacciotti

PMC · DOI: 10.3390/curroncol32050281 · Current Oncology · 2025-05-15

## TL;DR

This paper discusses ways to reduce long-term treatment side effects in children with brain tumors by adapting therapies and using supportive care.

## Contribution

The paper highlights risk-adapted treatment strategies and de-escalation to minimize late effects in pediatric CNS tumor survivors.

## Key findings

- Treatment techniques and risk-adapted approaches help reduce long-term toxicity.
- De-escalation of therapy when feasible can minimize late effects in survivors.
- Supportive therapy and surveillance are crucial for managing treatment-related complications.

## Abstract

Pediatric central nervous system (CNS) tumor survivors are highly susceptible to long-term toxicity due to tumor location and also the treatment received. Advancements in treatment techniques, risk-adapted approaches to therapy with adjustments to treatment regimens—including de-escalation when feasible—along with the addition of supportive therapy and surveillance in these survivors, serve to minimize and manage late effects of therapy.

## Linked entities

- **Diseases:** central nervous system tumor (MONDO:0002714)

## Full-text entities

- **Diseases:** tumor (MESH:D009369), central nervous system (CNS) tumor (MESH:D016543), Brain Tumors (MESH:D001932), Toxicity (MESH:D064420)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12109907/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12109907/full.md

## References

87 references — full list in the complete paper: https://tomesphere.com/paper/PMC12109907/full.md

---
Source: https://tomesphere.com/paper/PMC12109907